Grisma D. Patel

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 113 publications

Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy Combinations.

Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy Combinations.

Journal: The oncologist

Published: December 16, 2025

Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations.

Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations.

Journal: The oncologist

Published: December 16, 2025

Safe prescribing in cancer patients during the COVID-19 pandemic and outcomes following restart of cancer care following SARS-CoV-2 infection: The COV-SPOT initiative.

Safe prescribing in cancer patients during the COVID-19 pandemic and outcomes following restart of cancer care following SARS-CoV-2 infection: The COV-SPOT initiative.

Journal: International journal of cancer

Published: March 22, 2024

Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma.

Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 10, 2024

Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and report.

Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and report.

Journal: Contemporary clinical trials communications

Published: October 16, 2023

Advanced Triple-Negative Breast Cancer.

Advanced Triple-Negative Breast Cancer.

Journal: Seminars in oncology nursing

Published: September 10, 2023

A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).

A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).

Journal: Scientific reports

Published: February 03, 2023

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.

Journal: JAMA oncology

Published: December 22, 2022

The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research.

The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research.

Journal: British journal of cancer

Published: December 12, 2022

Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) team.

Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) team.

Journal: International journal of cancer

Published: November 02, 2022

COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.

COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 15, 2022

COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.

COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.

Journal: Journal of the National Cancer Institute

Published: January 06, 2022

Showing 1-12 of 113

Last Updated: 09/26/2026